Neurotransmission is the process your brain uses to send signals between nerve cells. It works through a combination of electrical impulses and chemical messengers, and it governs everything from moving your hand to feeling happy. Drugs, whether pharmaceutical or recreational, work by hijacking specific steps in this process to either amplify, dampen, or scramble those signals.
How a Signal Travels Between Neurons
Neurons don’t physically touch each other. They’re separated by a tiny gap called the synaptic cleft, which measures roughly 12 to 50 nanometers wide (thousands of times thinner than a human hair). Bridging that gap requires a chemical relay system that unfolds in a rapid, precise sequence.
It starts with an electrical impulse called an action potential. This pulse races down the length of a neuron until it reaches the very end, a structure called the axon terminal. When the electrical signal arrives, it triggers the release of chemical messengers called neurotransmitters, which are stored in tiny bubble-like packages waiting at the terminal’s edge. Those packages merge with the cell membrane and spill their contents into the synaptic cleft.
The neurotransmitters drift across the gap and latch onto receptors on the neighboring neuron, fitting like a key into a lock. That binding event opens or closes channels on the receiving cell, either encouraging it to fire its own electrical signal or making it less likely to do so. Once the message is delivered, specialized proteins called transporters vacuum the leftover neurotransmitters back into the original neuron so they can be repackaged and used again. This recycling step is critical: it controls how long and how strongly the signal lasts.
The Brain’s Major Chemical Messengers
Your brain uses dozens of neurotransmitters, but four carry the heaviest workload.
- Glutamate is the most abundant neurotransmitter in the brain and the primary excitatory signal. It drives thinking, learning, and memory formation. Too much glutamate activity can trigger seizures.
- GABA is the main inhibitory signal, essentially the brain’s braking system. It dials down neural activity and plays a central role in regulating anxiety, sleep, and concentration. When GABA activity drops too low, the result can be seizures, anxiety, or irritability.
- Dopamine fuels the brain’s reward system. It’s involved in motivation, pleasure, focus, and memory. Dysfunction in dopamine pathways is linked to Parkinson’s disease, ADHD, and schizophrenia.
- Serotonin is an inhibitory neurotransmitter that helps regulate mood, sleep, appetite, and pain perception. Imbalances are associated with depression, anxiety, and chronic pain conditions like fibromyalgia.
The balance between excitatory signals (mainly glutamate) and inhibitory signals (mainly GABA) is fundamental. When that balance tips too far in either direction, the consequences range from seizures to mood disorders to mania.
How Drugs Reach the Brain
Before a drug can alter neurotransmission, it has to cross the blood-brain barrier, a tightly sealed layer of cells lining the brain’s blood vessels that blocks most substances from entering. Small, fat-soluble molecules pass through most easily because they can dissolve directly into the barrier’s cell membranes. This is why heroin, which is more fat-soluble than morphine, reaches the brain faster and hits harder despite both drugs activating the same receptors.
Water-soluble molecules generally can’t slip through on their own. Some, like glucose and caffeine, get carried across by dedicated transport proteins that evolved to shuttle nutrients into the brain. Molecular size and electrical charge also matter: an uncharged molecule crosses the barrier 1,000 to 10,000 times more easily than its charged version. Molecules heavier than about 500 daltons (a unit of molecular weight) tend to be blocked entirely unless they hijack a transport system.
Mimicking Natural Neurotransmitters
Some drugs work because their molecular shape is close enough to a natural neurotransmitter that they can fool the brain’s receptors. These are called agonists. They bind to receptors and activate them, triggering a biological response. Your body already produces its own agonists: endorphins, for example, are natural pain-relieving chemicals that activate opioid receptors.
Opioid drugs like heroin and fentanyl mimic endorphins. They bind to opioid receptors (primarily the mu type) and activate them, which reduces neurotransmitter release from pain-signaling neurons and quiets those pathways. The result is pain relief and, at higher levels, euphoria. But because these drugs don’t activate neurons in exactly the same pattern as natural endorphins, they send abnormal signals through the network, which is part of what makes them so disruptive and addictive.
Similarly, marijuana contains compounds that mimic the brain’s own endocannabinoid neurotransmitters, binding to cannabinoid receptors throughout the brain. The fit isn’t perfect, though, and the signals produced differ in timing and intensity from what the brain generates on its own.
Not all agonists are equally powerful. A full agonist produces the maximum possible response from a receptor, while a partial agonist activates the receptor but can only produce a fraction of that maximum effect, no matter how much you take. Buprenorphine, used in addiction treatment, is a partial agonist at opioid receptors. It activates them enough to ease withdrawal symptoms but has a ceiling effect that makes overdose less likely.
Blocking Receptors
Antagonists take the opposite approach. They bind to receptors but don’t activate them. Instead, they sit in the lock and prevent the real key from turning. Naloxone, the overdose-reversal drug, is a classic antagonist. It has a strong attraction to opioid receptors and knocks opioid drugs off those receptors without producing any opioid effects of its own. The result is a rapid reversal of overdose symptoms like slowed breathing.
Some antagonists compete directly with agonists for the same binding spot. If you flood the system with enough of the agonist, it can eventually outcompete the antagonist and restore the original effect. Other antagonists are non-competitive: they bind to a different spot on the receptor and change its shape so the agonist can’t activate it regardless of concentration. Ketamine works this way, blocking a type of glutamate receptor by binding to a site inside the receptor’s channel rather than at the main docking point.
Flooding the Synapse
Rather than mimicking neurotransmitters, stimulants like cocaine and amphetamine work by increasing the amount of natural neurotransmitter, especially dopamine, lingering in the synaptic cleft.
Cocaine blocks the dopamine transporter, the recycling protein that normally sucks dopamine back into the neuron that released it. With the transporter blocked, dopamine accumulates in the synapse and keeps stimulating the receiving neuron far longer than it normally would. The result is an intense surge of pleasure, energy, and focus.
Amphetamine uses a different, more aggressive strategy. It doesn’t just block the dopamine transporter; it actually causes the transporter to pull away from the neuron’s surface and retreat into the cell’s interior. With fewer transporters available to clear dopamine from the synapse, dopamine levels rise. Amphetamine also triggers neurons to release extra dopamine in the first place, creating a double effect. Research published in PNAS showed that this transporter removal happens through a specific process where the cell’s internal machinery physically pulls the transporter proteins inward, reducing the neuron’s ability to clean up after itself.
Amplifying the Brain’s Braking System
Depressants like benzodiazepines and alcohol work on the other side of the equation, boosting inhibitory signaling. Both target GABA receptors, but in a nuanced way.
Benzodiazepines don’t activate GABA receptors directly. Instead, they bind to a separate site on the receptor and act as a volume knob, making the receptor more responsive when GABA arrives. This is called positive allosteric modulation. When GABA binds and opens the receptor’s channel (allowing chloride ions to flow in and quiet the neuron), a benzodiazepine makes that channel open wider or stay open longer. The neuron becomes harder to excite, producing sedation, reduced anxiety, and muscle relaxation.
This mechanism is important because it means benzodiazepines can only enhance signaling that’s already happening. They amplify existing GABA activity rather than creating it from scratch, which gives them a built-in safety margin compared to drugs that activate GABA receptors directly. Still, combining them with other depressants like alcohol (which also enhances GABA signaling through overlapping mechanisms) can push inhibition to dangerous levels.
How the Brain Adapts Over Time
The brain doesn’t passively accept being flooded with extra neurotransmitter activity. When a drug repeatedly overstimulates a receptor system, the brain compensates, and this is the foundation of tolerance and dependence.
One major adaptation is receptor downregulation. If a neuron is being bombarded with excessive stimulation, it physically removes receptors from its surface, pulling them inside the cell where they’re either recycled or broken down. Fewer receptors on the surface means the same dose of drug produces a weaker effect, so users need more to get the same result. With opioids, this process involves a chain of molecular events where the receptor is tagged by enzymes, grabbed by specialized proteins called arrestins, and then dragged into the cell interior through small pits that form in the membrane.
Different drugs trigger this adaptation at different rates. Some opioids cause rapid receptor removal (high-internalizing), while others produce slower, less dramatic changes. Interestingly, the drugs that cause less receptor removal don’t necessarily produce less tolerance. They may instead drive desensitization through different molecular pathways, where the receptor stays on the surface but becomes less responsive.
When the drug is removed after the brain has adapted, the system is left in an unbalanced state. A brain that downregulated its dopamine receptors in response to chronic stimulant use now has too few receptors for normal dopamine levels to work with. The result is withdrawal: the opposite of whatever the drug was doing. Stimulant withdrawal brings fatigue and depression. Depressant withdrawal brings anxiety, insomnia, and in severe cases, seizures. Opioid withdrawal brings heightened pain sensitivity and intense discomfort. The brain can recover, but depending on the substance and duration of use, restoring the original balance can take weeks to months.